Rachel Roubein

Washington, D.C.

National health-care reporter and author of The Health 202

Education: University of Maryland, BA in journalism

Rachel Roubein is a national health-care reporter for The Washington Post and author of The Health 202, a daily morning newsletter bringing readers inside everything from the health policy battles dominating Capitol Hill to the White House's handling of the coronavirus pandemic. She joined The Post in 2021 after covering health care at Politico, with a focus on Medicaid, Medicare and Obamacare. Roubein first started writing about health care at the Carroll County Times, a local newspaper in Maryland, and has since covered health policy at National Journal and The Hill. She has covered the fa
Latest from Rachel Roubein

How the Inflation Reduction Act might affect you — and change the U.S.

The package, while smaller than Democrats’ initial ambitions, would transform huge sectors of the U.S. economy and affect millions of Americans.

August 29, 2023

The GOP abortion split was on full display last night

They disagreed sharply over a federal abortion ban.

August 24, 2023

South Carolina’s highest court upholds strict abortion ban

South Carolina’s Supreme Court upheld a new law banning most abortions after roughly six weeks. The 4-1 decision is a reversal from when the court struck a similar law saying it violated the state constitution.

August 23, 2023

The first GOP debate is tonight. We have questions.

Here's what we'd ask the candidates if Health 202 was the moderator.

August 23, 2023

Some states tweak their Medicaid programs amid the unwinding process

Also in today’s edition: Federal regulators have approved the first maternal RSV vaccine administered during pregnancy to protect infants from severe illness. The Indiana Supreme Court rejected a request from abortion rights supporters to reconsider its ruling upholding a near-total ban.

August 22, 2023

The Supreme Court could again review a high-stakes abortion case

An appeals court has embraced limits on mifepristone.

August 17, 2023

Appeals court embraces abortion-pill limits, sets up Supreme Court review

The Supreme Court has ruled that mifepristone, a key abortion drug, will remain available for now under existing regulations while the litigation continues.

August 16, 2023

One year later, public awareness of new health law lags

The majority of Americans say they don’t know about provisions aimed at lowering the cost of prescription drugs in Medicare.

August 16, 2023

Decoding the latest uptick in covid-19

Many in the public health world say they aren’t worried at this moment.

August 15, 2023

Ohio vote energizes Dems to campaign even more on abortion

Democrats view abortion as a political winner in 2024.

August 10, 2023